The generic nature of the 3base technology is the probably most exciting part, I think. It can potentially be used anywhere where genetic identification is the bases of diagnosis based on my very rudimentary knowledge of biology. In that sense it does have the potential to become the next CSL. No wonder A seasoned fundie like Chris Abbott has been so supportive.
GSS Price at posting:
$1.14 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)